Table 3 Standardized Incidence Ratios (SIR) for second primary cancer after a testicular cancer diagnosis according to site. Geneva 1970–2012
Localisation of the second cancer | Observed | Expected | SIR | 95% CI | p-value |
|---|---|---|---|---|---|
Controlateral testis | 16 | 0.77 | 20.66 | [11.9–33.7] | < 0.001 |
Pancreas | 3 | 0.8 | 3.76 | [0.8–11] | 0.047 |
Bladder | 6 | 1.51 | 3.98 | [1.5–8.6] | 0.005 |
Prostate | 10 | 7.47 | 1.34 | [0.6–2.5] | 0.221 |
Stomach | 2 | 0.93 | 2.15 | [0.2–7.8] | 0.239 |
Lung | 6 | 5.4 | 1.2 | [0.4–2.4] | 0.385 |
All tumors (skin non-melanoma excluded) | 70 | 34.73 | 2.02 | [1.6–2.5] | < 0.001 |